Browsing by Author von Moos, Roger

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 3 of 3
Issue DateTitleAuthor(s)Citation
2017Cholesterol, cholesterol-lowering medication use, and breast cancer outcome in the BIG 1-98 studyCoates, Alan; Ahern, T; Borgquist, Signe; Colleoni, Marco; Debled, Marc; Ejlertsen, Bent; et al, Various; Garber, Judy; Giobbie-Hurder, Anita; Lang, Istvan; von Moos, Roger; NH&MRC Clinical Trials CentreCholesterol, cholesterol-lowering medication use, and breast cancer outcome in the BIG 1-98 study, Journal of Clinical Oncology, vol.35, 11, 2017,pp 1179-1188
2016Pain and analgesic use associated with skeletal-related events in patients with advanced cancer and bone metastasesMarx, Gavin; Body, Jean-Jacques; Brown, Janet; Cleeland, Charles; Damyanov, Danail; Egerdie, Blair; et al, Various; Fallowfield, L. J.; Palazzo, Felipe Salvador; Patrick, Donald; Stopeck, Alison; von Moos, Roger; SAHCS: MedicinePain and analgesic use associated with skeletal-related events in patients with advanced cancer and bone metastases, Supportive Care in Cancer, vol.24, 3, 2016,pp 1327-1337
2013Pain and health-related quality of life in patients with advanced solid tumours and bone metastases: integrated results from three randomized, double-blind studies of denosumab and zoledronic acidMarx, Gavin; Body, Jean-Jacques; Brown, Janet; Cleeland, Charles; Damyanov, Danail; Egerdie, Blair; et al, Various; Fallowfield, L. J.; Patrick, Donald; Stopeck, Alison; von Moos, Roger; MedicinePain and health-related quality of life in patients with advanced solid tumours and bone metastases: integrated results from three randomized, double-blind studies of denosumab and zoledronic acid, Supportive Care in Cancer, vol.21, 12, 2013,pp 3497-3507